Form 4 for MYGN MYRIAD GENETICS INC
Accepted 2022-10-11 00:00:00 ET · period of report 2022-10-09 · accession 0001628280-22-026252 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-10-11 | 2022-10-09 | MYGN | Verratti Mark | Chief Commercial Off | F - Tax | $19.62 | -8,366 | 233.0K | -3% | -$164.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-10-09 | F | D | 5,006 | $19.62 | 228,022 | D | — | — | |
| 2 | Common | Common Stock | 2022-10-09 | F | D | 3,360 | $19.62 | 233,028 | D | — | — |